SG11201906781VA - Antimicrobial compositions comprising copper-hydroxypyrone complexes - Google Patents

Antimicrobial compositions comprising copper-hydroxypyrone complexes

Info

Publication number
SG11201906781VA
SG11201906781VA SG11201906781VA SG11201906781VA SG11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA SG 11201906781V A SG11201906781V A SG 11201906781VA
Authority
SG
Singapore
Prior art keywords
copper
international
complexes
pct
peg
Prior art date
Application number
SG11201906781VA
Other languages
English (en)
Inventor
Jonathan Joseph Powell
Nuno Faria
Carlos Andre Passos Bastos
Original Assignee
Res & Innovation Uk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res & Innovation Uk filed Critical Res & Innovation Uk
Publication of SG11201906781VA publication Critical patent/SG11201906781VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201906781VA 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes SG11201906781VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1701944.9A GB201701944D0 (en) 2017-02-06 2017-02-06 Antimicrobial compositions and their uses
PCT/EP2018/052958 WO2018141989A1 (en) 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes

Publications (1)

Publication Number Publication Date
SG11201906781VA true SG11201906781VA (en) 2019-08-27

Family

ID=58462497

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201906781VA SG11201906781VA (en) 2017-02-06 2018-02-06 Antimicrobial compositions comprising copper-hydroxypyrone complexes

Country Status (10)

Country Link
US (1) US11000502B2 (pt)
EP (1) EP3576730A1 (pt)
JP (1) JP2020506201A (pt)
CN (1) CN110248654A (pt)
AU (1) AU2018216241A1 (pt)
BR (1) BR112019016189A2 (pt)
CA (1) CA3051519A1 (pt)
GB (1) GB201701944D0 (pt)
SG (1) SG11201906781VA (pt)
WO (1) WO2018141989A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111647533A (zh) * 2020-06-16 2020-09-11 科里思特(福建)生物科技有限公司 一种枯草芽孢杆菌及其制剂与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138155A (ja) * 1993-11-12 1995-05-30 Otsuka Pharmaceut Co Ltd 抗微生物剤
GB9621273D0 (en) * 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
WO2000018366A1 (en) 1998-09-23 2000-04-06 Unilever N.V. Oral composition with an improved teeth whitening effect
US6505233B1 (en) 1999-08-30 2003-01-07 Zaplet, Inc. Method for communicating information among a group of participants
JP2002255956A (ja) * 2001-02-27 2002-09-11 Sumitomo Chem Co Ltd 防カビ剤
JP2009256228A (ja) * 2008-04-15 2009-11-05 Lion Corp 液体口腔用組成物
GB201402672D0 (en) * 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions

Also Published As

Publication number Publication date
BR112019016189A2 (pt) 2020-04-14
US11000502B2 (en) 2021-05-11
CN110248654A (zh) 2019-09-17
WO2018141989A1 (en) 2018-08-09
US20190380996A1 (en) 2019-12-19
JP2020506201A (ja) 2020-02-27
AU2018216241A1 (en) 2019-08-29
GB201701944D0 (en) 2017-03-22
CA3051519A1 (en) 2018-08-09
EP3576730A1 (en) 2019-12-11

Similar Documents

Publication Publication Date Title
SG11201806624XA (en) Deposition of molybdenum thin films using a molybdenum carbonyl precursor
SG11201805070TA (en) Vapor disposition of silicon-containing films using penta-substituted disilanes
SG11201907650RA (en) Personal therapy and exercise monitoring and oversight devices, systems, and related methods
SG11201906534XA (en) Antifouling composition
SG11201908171TA (en) Compounds and compositions for treating hematological disorders
SG11201900606VA (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
SG11201408605UA (en) Methods for biodegradable derivatization of cellulosic surfaces
SG11201810466PA (en) Compositions and methods related to engineered fc constructs
SG11201806485RA (en) Pyrrolobenzodiazepine conjugates
SG11201809976PA (en) Protection of plant extracts and compounds from degradation
SG11201908114UA (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
SG11201805001UA (en) Method of treating influenza a
SG11201809395XA (en) Executable logic for processing keyed data in networks
SG11201407812SA (en) Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201407801VA (en) Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
SG11201810192TA (en) Antibacterial compositions
SG11201806544XA (en) Compounds and methods of treating rna-mediated diseases
SG11201901188VA (en) Metal powder feedstocks for additive manufacturing, and system and methods for producing the same
SG11201811341QA (en) Sugar composition
SG11201900123TA (en) Compositions and methods for treating frontotemporal dementia
SG11201804230PA (en) Ultra-low molecular weight amide/ester containing quaternary ammonium salts having short hydrocarbon tails
SG11201907950VA (en) Complexes for treating sensitivity